Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 76
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 44
Aging and cancer
Léa Montégut, Carlos López‐Otín, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 42
Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, large-sample informatics study
Song‐Bin Guo, Le-Sheng Hu, Jing‐Kai Huang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 17
Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access | Times Cited: 4
What is the role of microbial biotechnology and genetic engineering in medicine?
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 12
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 6
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 6
Exosomal PD-L1 in cancer and other fields: recent advances and perspectives
Manman Lu, Yu Yang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
Di Liu, Mengqiu Li, Zhiyao Zhao, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2806-2819
Closed Access | Times Cited: 5
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Effect of perioperative analgesia on immunity in lung cancer
Xiaomin Fan, Ziqi Huang, Z. J. Chen, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152867-152867
Open Access
A comprehensive pan-cancer examination of transcription factor MAFF: Oncogenic potential, prognostic relevance, and immune landscape dynamics
Fengze Cai, Shining Mao, Shu‐Fen Peng, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114105-114105
Closed Access
Circulating biomarkers for diagnosis, prognosis, and treatment response prediction in cancer
Lorenzo Galluzzi, Sheila Spada
International review of cell and molecular biology (2025), pp. xiii-xvii
Closed Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Peto’s paradox: 2 problems 2 answers
Chika Edward Uzoigwe
Frontiers in Ecology and Evolution (2025) Vol. 13
Open Access
Comprehensive analysis of TMEM9 in human tumors
Xuezhong Zhang, Lele Zhou, Shumin Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Overview on biomarkers for immune oncology drugs
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, Natalia V. Mitiushkina
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
Zhi Liang, Tian-hao Zhang, Jiajia Huang, et al.
PeerJ (2025) Vol. 13, pp. e19083-e19083
Open Access
Page 1 - Next Page

Scroll to top